John A. Michalek

Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA.

BiologicsMD, Inc. operates as early stage therapeutic development company. It focuses on developing highly-targeted or smart therapies for the treatment of hair loss diseases and conditions, as well as severe bone disorders. The company is headquartered in Fayetteville, AR.

Sevo Nutraceuticals, Inc. engages in the provision of licensing services. It also markets science-based nutraceuticals developed at research institution including body building supplements, diet aids, and pain reducers. The firm targets the normal adults and adults experiencing cognitive decline. The company is headquartered in Fayetteville, AR.

CardioWise, Inc. engages in commercializing patented, cardiac computed tomography machine learning analysis software that produces a quantified four dimensional image model of the human heart. Its heart analysis software combined with cardiac CT is a single diagnostic test that is able to provide quantitative analysis of heart wall motion, arteries, and valves with detail. The company was founded in 2010 and is headquartered in Fayetteville, AR.

ViroCyt, Inc. develops life science instrumentation and assays products for the analysis of viruses and microorganisms. The company was founded in 2012 and is headquartered in Broomfield, CO.

Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA.

The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.

InDevR, Inc. develops and delivers analytical tools for detection and characterization of biological molecules and microorganisms. The firm offers on the ampliPHOX Colorimetric Detection platform and Custom Arrays to enable its customers a low risk means to explore the high utility of focused microarrays. The company was founded by Kathy L. Rowlen, Laura Kuck and John W. Birks in 2003 and is headquartered in Boulder, CO.

VIC Technology Venture Development LLC (VIC Technology) is a venture capital firm founded in 2000 by Calvin R. Goforth. The firm is headquartered in Fayetteville, Arkansas.

Tesseract Structural Innovations, Inc. engages in the development and commercialization of vehicle safety solutions. Its flagship product, Uniform Deceleration Unit, is a structure that has the ability to absorb impact during a vehicle crash. The company was founded on June 4, 2015 and is headquartered in Fayetteville, AR.

Nob Hill Therapeutics, Inc. develops dry powder nebulizer (DPN) for the treatment of severe respiratory diseases, including non-cystic fibrosis bronchiectasis and lung infections. The company was founded in 2016 and is headquartered in Albuquerque, NM.

Vin-7 Solenic Medical LLC is headquartered in Fayetteville, AR.

Solenic Medical, Inc. operates as a medical device company. It develops and commercializes a method for preventing prosthetic joint infection (PJI) based on technology. The firm?s technology offers an apparatus for the eradication of biofilm from metallic implants. The company was founded by David Greenberg and Rajiv Chopra in 2019 and is headquartered in College Station, TX.

VIN-11 SFC Fluidics LLC provides medical devices. The company is headquartered in Fayetteville, AR.

VIN-9 Nob Hill Therapeutics LLC provides tourism and travel services. The company is headquartered in Fayetteville, AR.

VIN-14 Akeso Biomedical LLC engages in the healthcare sector. The company is headquartered in Fayetteville, AR.

VIN-15 Vixiar Medical LLC provides medical services. The company is headquartered in Fayetteville, VA.

Filtravate, Inc. develops and commercialize ultrafiltration membranes for applications in the bioprocessing and biopharmaceutical industries. The company was founded by Reza Foudazi in 2020 and is headquartered in Las Cruces, NM.

Neurexis Therapeutics, Inc. provides healthcare services. The company is headquartered in Aurora, CO.

VIN-17 Solenic Medical LLC engages in medical industry. The company is headquartered in Fayetteville, AR.

Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA.

VIN-32 BiologicsMD LLC provides biological services. The company is based in Fayetteville, AR. The CEO of the company is Robert Calvin Goforth.

Cellia Science, Inc. develops and commercializes blood cell analyzers that provide rapid, actionable blood cell counts at the point of care. The company was founded in 2021 and is based in Fayetteville, AR. Cellia Science's lead device provides neutrophil and platelet counts for chemotherapy patients at risk of neutropenia and thrombocytopenia, using label-free deep-UV imaging technology exclusively licensed from a third party. The technology will be applied to additional diseases with significant unmet need in the future. Kelly Mabry has been the CEO of the company since 2022.